Indicators of the human immunodeficiency virus drug resistance to antiretroviral drugs in HIV-infected individuals in the Siberian federal district in 2010-2012

Cover Page

Cite item

Full Text

Abstract

The prevalence of the mutations of resistance to the main three classes of antiretroviral agents in patients receiving antiretroviral therapy was tested. Among the main drug resistance mutations for the entire period of observation was a high frequency of the occurrence M184V mutation, K101E, K103N, Y181C, and G190S influencing the development of the HIV resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors. The problems of the practical application of the study of HIV drug resistance in the regions of the Siberian Federal District were emphasized.

About the authors

A. N. Kolomeets

Omsk Research Institute of Natural Focal Infections, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; Siberian Federal District Center for AIDS Prevention

Author for correspondence.
Email: arbitasfoc2@gmail.com

Anna Kolomeets, MD, PhD

644080, Omsk

644080, Omsk

Россия

E. S. Dovgopolyuk

Siberian Federal District Center for AIDS Prevention

Email: fake@neicon.ru
644080, Omsk Россия

I. V. Sergeeva

Siberian Federal District Center for AIDS Prevention

Email: fake@neicon.ru
644080, Omsk Россия

V. K. Yastrebov

Omsk Research Institute of Natural Focal Infections, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Email: fake@neicon.ru
644080, Omsk Россия

A. T. Tyumentsev

Siberian Federal District Center for AIDS Prevention

Email: fake@neicon.ru
644080, Omsk Россия

References

  1. Беляков Н.А., Рахманова А.Г., ред. Вирус иммунодефицита человека – медицина: руководство для врачей. 2-е изд. СПб: Балтийский медицинский образовательный центр; 2011.
  2. Покровский В.В., ред. ВИЧ-1-инфекция и СПИД: клинические рекомендации. 2-е изд., перераб. и доп. М.: ГЭОТАР-МЕД; 2010.
  3. Львов Д.К., ред. Медицинская вирусология. М.: МИА; 2008.
  4. Урываев Л.В., Бобкова М.Р., Лаповок И.А. ВИЧ-1-инфекция – вызов человечеству. Есть ли шансы победить заболевание? Вопросы вирусологии. 2012; Приложение 1: 104–26.
  5. Maldarelli F. HIV Drug Resistance. In: Zeichner S., Read J., eds. Textbook of Pediatric HIV Care. Cambrige: 2006 : 334–54.
  6. Sato H., Orenstein J., Dimitrov D., Martin M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 1992; 2 (186): 712–24.
  7. Mittler J.E., Markowitz M., Ho D.D., Perelson A.S. Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS. 1999; 11 (13): 1415–7.
  8. Paoloni-Giacobino A., Rossier C., Papasavvas M.P., Antonarakis S.E. Frequency of replication/transcription errors in (A)/(T) runs of human genes. Hum. Genet. 2001; 1 (109): 40–7.
  9. O’Neil P.K., Sun G., Yu H., Ron Y., Dougherty J.P., Preston B.D. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J. Biol. Chem. 2002; 41 (277): 38 053–61.
  10. Persaud D., Pierson T., Ruff C., Finzi D., Chadwick K.R., Margolick J.B. et al. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. J. Clin. Invest. 2000; 7 (105): 995– 1003.
  11. Ruff C.T., Ray S.C., Kwon P., Zinn R., Pendleton A., Hutton N. et al. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 2002; 18 (76): 9481–92.
  12. Kellam P., Larder B.A. Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J. Virol. 1995; 2 (69): 669–74.
  13. Gomez Carrillo M., Avila M., Hierholzer J., Pando M., Martinez P.L., McCutchan F.E. et al. Mother to child HIV type 1 transmission in Argentina: BF recombinants have predominated in infected children since the mid-1980s. AIDS Res. Hum. Retrovirus. 2002; 7 (18): 477–83.
  14. Лечить нельзя отказывать: отчет по результатам исследований силами сообщества людей, живущих с ВИЧ-1. Available at: http://itpcru.org/netcat_files/10/196/Zakupki_FINAL.pdf.
  15. Определение чувствительности вируса иммунодефицита человека к лекарственным препаратам: Методические рекомендации № 5956–РХ.: утв. зам. Министра здравоохранения и соц. развития Российской Федерации 06.08.2007.
  16. Major HIV Drug Resistance Mutations. Available at: http://hivdb.stanford.edu/pages/download/resistanceMutations_handout.pdf.
  17. Wolf E. HIV Resistance testing. In: Hoffmann C., Rockstroh J.K., Kamps B.S., eds. HIV Medicine. 2007: 321–52.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Kolomeets A.N., Dovgopolyuk E.S., Sergeeva I.V., Yastrebov V.K., Tyumentsev A.T.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies